Americans will likely see life begin to return to normal this summer as coronavirus cases, hospitalizations and deaths continue to decline, former Assistant Secretary for Health Brett Giroir told "The Story" Monday.
The U.S. exceeded a tragic milestone as the nation recorded over half a million lives lost to the novel coronavirus, according to data from Johns Hopkins University.
Amid emerging coronavirus variants, the “direction of the future” will be in developing “potent antivirals” that directly act on the SARS-CoV-2 virus, Dr. Anthony Fauci said on Monday. Fauci, who was partaking in the White House’s COVID-19 briefing, said the nation would need to approach therapeutics similar to the “highly successful drug development program for HIV as well as Hepatitis C.”
COVID-19 survivors who have gotten a first dose of COVID-19 vaccine are generating immune responses that might render a second shot unnecessary, potentially freeing up limited vaccine supply for more people, several new research papers suggest.
GlaxoSmithKline and Sanofi on Monday announced the start of a new Phase 2 trial involving their protein-based COVID-19 vaccine candidate after facing a setback in December.
French drug maker Sanofi, battling development delays with its own vaccine candidates against COVID-19, is turning over more of its vaccine production facilities to industrial competitors, teaming up with Johnson & Johnson to produce millions of doses of its rival coronavirus vaccine.
A Michigan woman contracted COVID-19 and died last fall after she got a double-lung transplant from a donor who turned out to have the virus, according to a study.
White House chief medical adviser Dr. Anthony Fauci said Thursday that it's "very likely" that family members who have been vaccinated against coronavirus can safely hug each other.
Some Texas hospital officials are scrambling to bring in clean water supply while delaying elective surgeries after brutal winter weather resulted in a gradually resolving power, and now emerging water, crisis this week.
No concerning safety issues were associated with either the Pfizer and BioNTech or Moderna coronavirus vaccines during the first month of shots, the Centers for Disease Control and Prevention (CDC) reported Friday